Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check3 days agoChange DetectedNew revision entry v3.6.2 has been added to the study record history, indicating an updated version of the record. The previous revision v3.6.0 is removed in this update, reflecting the revised history list.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe latest history entry records that the study is no longer enrolling participants and notes a revision to v3.6.0; the previous revision v3.5.5 is removed from the visible history.SummaryDifference0.3%

- Check25 days agoChange DetectedThe study record history shows an update on 2026-06-02 changing the status to Active, not recruiting and adding new sections for Contacts/Locations, Study Status, and Recruitment Status. This update is tracked under revision v3.5.5, replacing the previous v3.5.4 which listed Recruiting.SummaryDifference0.7%

- Check46 days agoChange DetectedFooter revision label updated from v3.5.3 to v3.5.4, indicating a minor platform release. No study content or page functionality changes are introduced by this update.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry (version 20) was added to the Record History with a Study Status update dated 2026-04-21, and a subsequent 2026-04-24 entry records another Study Status change.SummaryDifference0.3%

- Check67 days agoChange DetectedThe page’s footer/test tooling label was updated from Revision v3.5.2 to v3.5.3, indicating a maintenance/version release rather than a change to the clinical trial record itself.SummaryDifference0.1%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.